KEFEA: Re-elected president

Pfizer’s Cyprus Business Manager Kyriakos Mikellis has been re-elected for the next two years as president of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA). 

ADVERTISEMENT

Mikellis stressed that KEFEA’s priorities in the near future will be the implementation of a viable and effective National Health Scheme in Cyprus and the realisation of European directive and falsified medicines. Jacqueline Anastassiades, Managing Director of Merck Sharp & Dohme (MSD) in Cyprus, was elected as vice president. 

KEFEA, founded in 2006, represents the pharmaceutical industry in Cyprus with the aim to implement a sustainable healthcare system for all Cypriots. It’s members are relevant healthcare stakeholders.

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!